Zapis integralności funkcjonalnej bariery na komórkach śródbłonka naczyniowego bEnd.3 poprzez transśródbłonkową detekcję oporu elektrycznego

Overview

This study presents a reliable in vitro model of the blood-brain barrier (BBB) using mouse cerebral vascular endothelial cells (bEnd.3). The model assesses transmembrane electrical resistance (TER) to evaluate the integrity of the BBB, facilitating drug screening for central nervous system treatments.

Key Study Components

Area of Science

• Cell Biology
• Neuroscience
• Pharmacology

Background

• The blood-brain barrier is crucial for maintaining homeostasis in the central nervous system.
• Traditional in vitro models are less effective for drug testing due to limitations in cellular complexity.
• This study addresses those limitations by presenting a simpler, non-invasive method.

Purpose of Study

• To improve the assessment of BBB integrity through TER measurement.
• To facilitate the screening of drugs targeting central nervous system disorders.
• To verify the relationship between TER values and tight junction protein expression.

Methods Used

• The study utilized bEnd.3 cell culture, which was seeded and cultured in a 96-well plate format.
• Key interventions included the addition of cobalt chloride to assess cellular viability and barrier integrity.
• TEER values were recorded over time to determine the formation and stability of the BBB model.
• Statistical analysis was employed to compare control and treated groups.

Main Results

• Results indicated a significant reduction in TEER values upon treatment with cobalt chloride, indicating compromised BBB integrity.
• The study showed the potential of using TER as a reliable method for assessing drug effects on the BBB.
• Stability of the cell barrier was reached by day five, underscoring the method's effectiveness.

Conclusions

• This study demonstrates a simplified and effective approach to assess BBB integrity in drug development.
• Results could enhance understanding of therapeutic interventions for central nervous system diseases.
• The methods outlined may be adapted for broader applications in pharmacological research.

Frequently Asked Questions